Abstract
No public abstract is available from the verified source records.
Natsuki Hata, Takaharu Hirai, Naoko Umeda, Xiaoyue Xiao, Christophe H. Morisseau, Bruce D. Hammock, Taeko Harada, Akemi Okumura, Chikako Nakayasu, Kenji J. Tsuchiya, Tomoko Nishimura, Hideo Matsuzaki
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study
10.1016/j.cyto.2012.11.015 · 2013
Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort
10.1016/j.bbi.2011.09.003 · 2012
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
10.1016/j.jneuroim.2010.10.025 · 2011
Chemokines and their receptors in the central nervous system
10.1006/frne.2001.0214 · 2001
The immune system and developmental programming of brain and behavior
10.1016/j.yfrne.2012.08.006 · 2012
Eicosanoids
10.1042/ebc20190083 · 2020
Placental abundance of arachidonic acid metabolites is reduced in preterm placentas but is not altered in fetal growth restriction
10.1016/j.plefa.2026.102761 · 2026
Autism risk factors: genes, environment, and gene-environment interactions
10.31887/dcns.2012.14.3/pchaste · 2012
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta
10.1097/hjh.0000000000000942 · 2016
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Monocyte chemoattractant protein-1 (MCP-1): an overview
10.1089/jir.2008.0027 · 2009
Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues
10.1177/002215540405200403 · 2004
Maternal immune activation: implications for neuropsychiatric disorders
10.1126/science.aag3194 · 2016
Advances in our understanding of oxylipins derived from dietary PUFAs
10.3945/an.114.007732 · 2015
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study
10.1186/2040-2392-2-13 · 2011
Soluble epoxide hydrolase: gene structure, expression and deletion
10.1016/j.gene.2013.05.008 · 2013
Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders
10.3389/fphar.2019.00036 · 2019
Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for mothers and children (HBC study)
10.1111/pcn.13710 · 2024
Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
10.1186/s12974-019-1508-2 · 2019
Replication of standardized ADOS domain scores in the simons simplex collection
10.1002/aur.1474 · 2015
Epoxylipids and soluble epoxide hydrolase in heart diseases
10.1016/j.bcp.2021.114866 · 2022
Sex differences in immune responses
10.1038/nri.2016.90 · 2016
Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia
10.2741/2889 · 2008
Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo
10.1194/jlr.m031914 · 2013
Autism
10.1016/s0140-6736(13)61539-1 · 2014
Nanobody based immunoassay for human soluble epoxide hydrolase detection using polymeric horseradish peroxidase (PolyHRP) for signal enhancement: the rediscovery of PolyHRP?
10.1021/acs.analchem.7b01247 · 2017
Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications
10.1159/000345599 · 2013
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism
10.1023/a:1005592401947 · 2000
Unresolved referenced work
2012
Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney
10.1016/j.jbc.2021.100667 · 2021
Maternal lifestyle and environmental risk factors for autism spectrum disorders
10.1093/ije/dyt282 · 2014
Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation
10.1073/pnas.1819234116 · 2019
Activity of sEH and oxidant status during systemic bovine coliform mastitis
2021
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
10.1186/s13229-017-0121-4 · 2017
Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health
10.1146/annurev-pharmtox-011112-140244 · 2013
Soluble epoxide hydrolase dimerization is required for hydrolase activity
10.1074/jbc.m112.429258 · 2013
Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression
10.2133/dmpk.24.438 · 2009
Synaptic pruning by microglia is necessary for normal brain development
10.1126/science.1202529 · 2011
Polymorphisms in human soluble epoxide hydrolase
10.1124/mol.64.2.482 · 2003
Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase
10.1073/pnas.1922287117 · 2020
Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes
10.1002/jnr.21827 · 2009
Soluble epoxide hydrolase: mechanisms and therapeutic potential in psychiatric and neurological disorders
10.1016/bs.apha.2024.10.007 · doi-reference
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia
10.1038/jcbfm.2009.65 · doi-reference
Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease
10.1165/rcmb.2011-0359oc · doi-reference
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
10.1016/j.pharmthera.2017.06.006 · doi-reference
Searching for very early precursors of autism spectrum disorders: the Hamamatsu Birth Cohort for mothers and children (HBC)
10.1017/s2040174410000140 · doi-reference
Sex differences in immune responses
10.1126/science.abe7199 · doi-reference
Cohort profile: Hamamatsu birth cohort for mothers and children (HBC study)
10.1093/ije/dyv290 · doi-reference
Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target
10.1016/j.neubiorev.2018.01.010 · doi-reference
Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders
10.1371/journal.pone.0020470 · doi-reference
Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure
10.1016/j.abb.2004.05.003 · doi-reference
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
10.1073/pnas.0409591102 · doi-reference
Altered plasma levels of chemokines in autism and their association with social behaviors
10.1016/j.psychres.2016.07.057 · doi-reference
Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years - autism and developmental disabilities monitoring network, 16 sites, United States, 2022
10.15585/mmwr.ss7402a1 · doi-reference
The role of soluble epoxide hydrolase in preeclampsia
10.1016/j.mehy.2017.07.033 · doi-reference